BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8134777)

  • 1. Comparison of ivermectin and benzyl benzoate for treatment of scabies.
    Glaziou P; Cartel JL; Alzieu P; Briot C; Moulia-Pelat JP; Martin PM
    Trop Med Parasitol; 1993 Dec; 44(4):331-2. PubMed ID: 8134777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ivermectin and benzyl benzoate lotion for scabies in Nigerian patients.
    Sule HM; Thacher TD
    Am J Trop Med Hyg; 2007 Feb; 76(2):392-5. PubMed ID: 17297053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of scabies with oral ivermectin in Nigeria.
    Nnoruka EN; Agu CE
    Trop Doct; 2001 Jan; 31(1):15-8. PubMed ID: 11205591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of a new synergized pyrethrins thermofobic foam in comparison with benzyl benzoate in the treatment of scabies in convicts: the ISAC study (Studio Della scabbia in ambiente carcerario).
    Biele M; Campori G; Colombo R; De Giorgio G; Frascione P; Sali R; Starnini G; Milani M;
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):717-20. PubMed ID: 16836502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries.
    Brooks PA; Grace RF
    J Paediatr Child Health; 2002 Aug; 38(4):401-4. PubMed ID: 12174005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies.
    Goldust M; Rezaee E; Raghifar R
    Cutan Ocul Toxicol; 2014 Dec; 33(4):333-6. PubMed ID: 23431958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of topical and oral ivermectin in the treatment of human scabies.
    Panahi Y; Poursaleh Z; Goldust M
    Ann Parasitol; 2015; 61(1):11-6. PubMed ID: 25911032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of topical benzyl benzoate vs. oral ivermectin in treating scabies: A randomized study.
    Meyersburg D; Welponer T; Kaiser A; Selhofer S; Tatarski R; Handisurya A; Bauer JW
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):160-165. PubMed ID: 36097258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies.
    Ranjkesh MR; Naghili B; Goldust M; Rezaee E
    Ann Parasitol; 2013; 59(4):189-94. PubMed ID: 24791346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of ELM to monitor the success of antiscabietic treatment. Epiluminescence light microscopy.
    Haas N; Sterry W
    Arch Dermatol; 2001 Dec; 137(12):1656-7. PubMed ID: 11735726
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream.
    Goldust M; Rezaee E; Raghifar R; Hemayat S
    Ann Parasitol; 2013; 59(2):79-84. PubMed ID: 24171301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Crusted (Norwegian) scabies in Dakar (Senegal)].
    Ndiaye B; Develoux M; Dieng MT
    Sante; 1999; 9(4):243-8. PubMed ID: 10623872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European guideline for the management of scabies.
    Salavastru CM; Chosidow O; Boffa MJ; Janier M; Tiplica GS
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1248-1253. PubMed ID: 28639722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial.
    Ly F; Caumes E; Ndaw CA; Ndiaye B; Mahé A
    Bull World Health Organ; 2009 Jun; 87(6):424-30. PubMed ID: 19565120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, acceptability and cost effectiveness of four therapeutic agents for treatment of scabies.
    Abdel-Raheem TA; Méabed EM; Nasef GA; Abdel Wahed WY; Rohaim RM
    J Dermatolog Treat; 2016 Oct; 27(5):473-9. PubMed ID: 27027929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit analysis of ivermectin, permethrin and benzyl benzoate in the management of infantile and childhood scabies.
    Elgart ML
    Expert Opin Pharmacother; 2003 Sep; 4(9):1521-4. PubMed ID: 12943481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies.
    Alberici F; Pagani L; Ratti G; Viale P
    Br J Dermatol; 2000 May; 142(5):969-72. PubMed ID: 10809857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Inquiry: What is the most effective treatment for scabies?
    Campbell JJ; Paulson CP; Nashelsky J
    J Fam Pract; 2017 Aug; 66(8):E11-E12. PubMed ID: 28783773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for treatment failure in scabies: a cohort study.
    Aussy A; Houivet E; Hébert V; Colas-Cailleux H; Laaengh N; Richard C; Ouvry M; Boulard C; Léger S; Litrowski N; Benichou J; Joly P;
    Br J Dermatol; 2019 Apr; 180(4):888-893. PubMed ID: 30376179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of scabies: Comparison of permethrin 5% versus ivermectin.
    Goldust M; Rezaee E; Hemayat S
    J Dermatol; 2012 Jun; 39(6):545-7. PubMed ID: 22385121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.